LPL Financial’s FibroBiologics FBLG Stock Holding History

LPL Financial’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-879	Closed	-$9.6K	–	6095
2025 Q3	$9.6K	Buy	879 +250	+40%	+$2.99K	﹤0.01%	5778
2025 Q2	$7.82K	Buy	+629	New	+$11.3K	﹤0.01%	5530

Other funds holding FBLG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ANTB

AMG National Trust Bank Greenwood Village, Colorado $4.88B AUM 24.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LPL Financial's FBLG Position: Q4 2025 in Review

LPL Financial sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 879 shares — an estimated $9.6K sold.

LPL Financial first reported a position in FBLG in Q2 2025 and held it in 2 quarters. The position peaked at $9.6K in Q3 2025. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

LPL Financial reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
LPL Financial sold 879 FibroBiologics shares in Q4 2025, an estimated $9.6K.
LPL Financial first reported a position in FibroBiologics in Q2 2025 and held it in 2 quarters.
LPL Financial's FibroBiologics position peaked at $9.6K in Q3 2025.
45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on LPL Financial's 13F filing for Q4 2025, filed 11 Feb 2026.